Comment from European Medicines Agency
AnonymousSupportGovernment
Summary: The Methodology Working Party of the European Medicines Agency submitted comments providing technical feedback and suggestions for the finalization of the draft guidance. They offer specific recommendations on clarifying adaptive design features, multiplicity, and the scope of basket trials within the master protocols.
See attached file(s)